跳至主要内容
临床试验/JPRN-UMIN000008238
JPRN-UMIN000008238已完成未知

Impact of alogliptin on coronary flow reserve evaluated by magnetic resonance imaging - Impact of alogliptin on coronary flow reserve evaluated by magnetic resonance imaging

Kanagawa Cardiovascular and Respiratory Center0 个研究点目标入组 50 人开始时间: 2012年6月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Type 1 diabetes mellitus 2. Patient who already takes DPP4 inhibitors 3. Severe renal dysfunction (eGFR<30mL/min/1.73m2) 4. General contraindication to MRI (Claustrophobia, after pacemaker implantation etc.) 5. Patients who cannot hold breathe for about 10 seconds due to dyspnea 6. Contraindication to adenosine triphosphate infusion (asthma, advanced atrioventricular block etc.)

研究者

相似试验

Impact of alogliptin on coronary flow reserve... | 临床试验